Avadomide (CC 122) is an orally effective cereblon modulator. avadomide modulates cereblon E3 ligase activity and induces apoptosis in diffuse large B-cell lymphoma (DLBCL) cells. Avadomide has antitumor and immunomodulatory activities. CC-122 is more potent in degrading IKZF1 and IKZF3 than lenalidomide and has broader and enhanced antiproliferative activity in ABC- and GCB-DLBCL cell lines.
Molecular Weight:
286.29
Purity:
>99%
CAS Number:
[1015474-32-4]
Target:
E1/E2/E3 Enzyme
* VAT and and shipping costs not included. Errors and price changes excepted